CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Metastatic Castration-Resistant Prostate Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
<< View More Conferences
2018 ASCO Annual Meeting
Oncology Conference Multimedia
View more videos >>
Oncology Conference Articles
NGS Established as Most Cost-Effective Genetic Test for Metastatic NSCLC
Next-generation sequencing in metastatic non-small cell lung cancer can save Center for Medicare and Medicaid Services payers $1.4 million to $2.1 million.
Symptom Tracking System Reduces Severity in Patients With Head and Neck Cancer
Patients who used mobile and sensor technology to track their symptoms demonstrated reduced severity of their symptoms compared with patients who received standard care.
Despite USPSTF Recommendations and Medicaid Coverage, Data Show Low Lung Cancer Screening Rate
A total 1.9% of more than 7.6 million current and former heavy smokers in the United States underwent lung cancer screening in 2016, suggesting that it remains inadequate despite USPTF recommendations.
Shorter Trastuzumab Duration Matches 12-Month Standard for Early HER2+ Breast Cancer
A shorter 6-month course of adjuvant trastuzumab (Herceptin) was found to be noninferior for disease-free survival compared with the standard 12-month schedule for patients with HER2-positive early breast cancer.
Nelarabine Boosts 4-Year DFS Above 90% in Pediatric/AYA T-Cell Cancers
Adding nelarabine to escalating-dose methotrexate induced a 4-year disease-free survival rate of 91% in a cohort of pediatric and young adult patients with newly diagnosed T-cell cancers.
Cognitive Behavior Therapy, Acupuncture Improve Insomnia Symptoms in Cancer Survivors
Both cognitive behavior therapy for insomnia (CBT-I) and acupuncture produced clinically meaningful improvements in insomnia severity scores for cancer survivors, but data from the randomized CHOICE clinical trial showed that CBT-I was more effective overall for reducing the severity of insomnia.
Burden of Cardiovascular Disease in Prostate Cancer
The Role of Patient Education in Side Effect Management
Larotrectinib Inches Closer to FDA Approval for TRK+ Cancers
Tocilizumab Resolves CRS in Pediatric B-ALL Without Reducing Tisagenlecleucel Efficacy
Apalutamide Reduces Risk of PSA Progression by 94% in Nonmetastatic CRPC
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.